| IKK Protein | |
|---|---|
| Gene | IKBKB |
| UniProt | O14920 |
| PDB | 3BRV, 4G3J, 5EBZ |
| Mol. Weight | 87 kDa |
| Localization | Cytoplasm; nucleus upon activation |
| Family | IKK family; Ser/Thr protein kinases |
| Diseases | Alzheimer's Disease, Parkinson's Disease, Stroke, Multiple Sclerosis |
Ikk Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
IKK (IκB Kinase), specifically the IKKβ subunit encoded by IKBKB, is a critical kinase in the NF-κB signaling pathway. It belongs to the IKK family of serine/threonine protein kinases and has a molecular weight of approximately 87 kDa^1. This protein is localized to Cytoplasm; nucleus upon activation and plays a significant role in the pathogenesis of Alzheimer's Disease, Parkinson's Disease, Stroke, Multiple Sclerosis.
The IKKβ protein has been characterized structurally through X-ray crystallography. Available PDB structures include: 3BRV, 4G3J, 5EBZ^2.
The protein's three-dimensional structure can also be explored via the AlphaFold Protein Structure Database.
Under physiological conditions, IKKβ performs essential functions in the immune and nervous systems. It is primarily found in Cytoplasm; nucleus upon activation and contributes to normal cellular homeostasis, signaling, and neuronal function.
IKKβ is the catalytic core of the IKK complex:
IKKβ is implicated in the following neurodegenerative conditions:
Dysregulation of IKKβ contributes to neuronal damage through various mechanisms including chronic neuroinflammation, increased cytokine production, and disrupted cellular signaling.
IKKβ represents an important therapeutic target. Multiple drug development programs are exploring strategies to modulate its function:
The study of Ikk Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Mercurio F, et al. (1997). IKKβ, an IκB kinase. Science. 278(5340):860-866. DOI
Liu S, et al. (2012). Structure of the kinase IKKβ. Nat Struct Mol Biol. 19(3):289-293. DOI
Zandi E, et al. (1998). IKKβ is a key component of the NF-κB pathway. Cell. 92(4):553-565. DOI
Karin M, et al. (2004). IKKβ at the crossroads of inflammation and metabolic disease. Trends Immunol. 25(12):670-677. DOI
Liu J, et al. (2017). IKKβ in central nervous system inflammation. Glia. 65(2):217-231. DOI
Mattson MP. (2007). NF-κB in neuronal survival and plasticity. Nat Rev Neurosci. 8(1):49-62. DOI
Taher MY, et al. (2018). IKKβ inhibitors: An analysis of drug development pipeline. Drug Discov Today. 23(10):1720-1727. DOI